335 filings
Page 7 of 17
424B5
u68fkfsarrkpyir2ru
14 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
s664xogq
13 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
r5kf13sfj
12 Jun 17
GenMark Receives FDA 510(k) Market Clearance for its ePlex® Instrument and Respiratory Pathogen Panel
12:00am
424B5
d3qay7e69e
12 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
ey7 ds7u5
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
SD
ceqkz rnx0
31 May 17
Conflict minerals disclosure
12:00am
8-K
0258fbz
31 May 17
Submission of Matters to a Vote of Security Holders
12:00am
CT ORDER
pi2g ua5mkv94rtge7
9 May 17
Confidential treatment order
12:00am
8-K
dua 6zb92brxwht1
2 May 17
GenMark Diagnostics Reports First Quarter 2017 Results
12:00am
8-K
ag29dlb
20 Apr 17
GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Fungal Pathogen Panel
12:00am
DEFA14A
z0g110gv wk9dt
13 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
5ybngh
6 Mar 17
Confidential treatment order
12:00am
S-8
287m4w5yzxtp5
1 Mar 17
Registration of securities for employees
12:00am
8-K
3k3 xv8ddlz
28 Feb 17
GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results
12:00am
8-K
jgl e5b1phew8
24 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
khwd8o
10 Jan 17
GenMark Announces Preliminary Q4 2016 Financial Results
12:00am
CT ORDER
113n9573kaw9i
21 Nov 16
Confidential treatment order
12:00am